Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stem Cell Transplantation for Premature Ovarian Failure
NCT03069209Phase 2Unknown
- Sponsor
- Stem Cells Arabia
- Start
- Jan 2015
- Primary completion
- Jun 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous bone marrow-derived stem cells in primary ovarian insufficiency (POI), sponsored by Stem Cells Arabia. Primary endpoint: Return of menstrual cycle at 6 months. Status: unknown.
02
Drugs
autologous bone marrow-derived stem cells
03
Conditions
primary ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT03069209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03069209.